Anemo Labs raised £700,000 in pre-seed funding to develop an AI-enabled electronic nose for detecting disease-related compounds.
- Amount
- $950K
- Stage
- Pre-Seed
- Announced
- 9 September 2026
- Leads
- Zinc, SFC Capital
- Other investors
- Innovate UK
- Use of funds
- Further developing sensor chemistry, expanding smell data collection and labelling, and validating its olfactory diagnostics platform with clinical partners.
- Checked
- Amount and date checked against the press source